Eko Devices
Trial Pipeline
Data Collection Using Eko Digital Devices in a Clinical Setting
NCT07227376
Improvement of an Algorithm to Detect Structural Heart Murmurs in Adult Patients Using Electronic Stethoscopes
NCT07202104
Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope
NCT07136623
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
NCT07087613
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
NCT05873387
Data Collection For Adventitious Lung Sounds Algorithm Using Eko Digital Devices in a Clinical Setting
NCT07360522
Dialysis Access Monitoring Using a Digital Stethoscope-Based Deep Learning System
NCT05105503
Development of an Algorithm to Differentiate Heart Murmurs Using Electronic Stethoscopes
NCT04400513
What the Pipeline for Eko Devices Shows
According to the ClinicalTrials.gov registry, Eko Devices is linked to 63 US clinical trials across every stage of research activity. Of those, 60 studies are currently recruiting — about 95% of the sponsor's indexed portfolio — and 2 are already marked complete, representing roughly 3% of the total. Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
The phase mix for Eko Devices reports 0 late-stage studies (Phase 3 and Phase 4 combined) and 0 earlier-phase studies (Phase 1 and Phase 2). A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work — safety, dosing, and early signal detection — and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
The top therapeutic focus area indexed for Eko Devices is Lung Diseases with 2 linked trials, and 9 other condition areas appear in the top list above. That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice — verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology — how this data is sourced, computed, and verified.